Durable and Clinically Meaningful Responses Reported from Phase 1/2 Studies of DTX401 for GSDIa and DTX301 for OTC Phase 3...
data
The MarketWatch News Department was not involved in the creation of this content. Dec 11, 2020 (The Expresswire) -- "Haptic...
The MarketWatch News Department was not involved in the creation of this content. Dec 02, 2020 (The Expresswire) -- 5G...